
Ghl Pharma & Diagnostic Private Limited
Medical and diagnostic services for humans and animals, including pharmacies and laboratories.
Medical and diagnostic services for humans and animals, including pharmacies and laboratories.
Ghl Pharma & Diagnostic Private Limited (GPDPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2022 (Two years and ten months 11 days old ). Its registered office is in South Delhi, Delhi, India.
The Corporate was formerly known as Global Health Pharmaceutical Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ghl Pharma & Diagnostic Private Limited India are Anup Jha as CFO and Sanchit Ralhan as Company Secretary. Rajdeep Panwar, Yogesh Gupta, Naresh Trehan, and One other member serve as directors at the Company.
South Delhi, Delhi, India
+91-XXXXXXXXXX
U85110DL2022PTC400942
400942
Private Limited Indian Non-Government Company
29 Jun 2022
19 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anup Jha | CFO | 09-Aug-2023 | Current |
Sanchit Ralhan | Company Secretary | 01-Sep-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajdeep Panwar ![]() | Director | 19-Sep-2023 | Current |
Yogesh Gupta ![]() | Additional Director | 18-Apr-2024 | Current |
Naresh Trehan ![]() | Director | 29-Jun-2022 | Current |
Pankaj Sahni ![]() | Director | 29-Jun-2022 | Current |
Ghl Pharma & Diagnostic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Ghl Pharma & Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Naresh Trehan and Pankaj Sahni are mutual person
Naresh Trehan and Pankaj Sahni are mutual person
Naresh Trehan and Pankaj Sahni are mutual person
Naresh Trehan is a mutual person
Naresh Trehan is a mutual person
Naresh Trehan and Pankaj Sahni are mutual person
There are no open charges registered against the company as per our records.
Ghl Pharma & Diagnostic has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ghl Pharma & Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ghl Pharma & Diagnostic's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Yogesh Kumar Gupta was appointed as a Additional Director was appointed as a Additional Director on 18 Apr 2024 & has been associated with this company since 1 year 21 days .
Ghl Pharma & Diagnostic Private Limited last Annual general meeting of members was held on 19 Sep 2023 as per latest MCA records.
Rajdeep Panwar was appointed as a Director was appointed as a Director on 19 Sep 2023 & has been associated with this company since 1 year 7 months .
Anup Kumar Jha was appointed as a Cfo was appointed as a Cfo on 09 Aug 2023 & has been associated with this company since 1 year 9 months .
Ghl Pharma & Diagnostic Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Naresh Trehan was appointed as a Director was appointed as a Director on 29 Jun 2022 & has been associated with this company since 2 years 10 months .
Ghl Pharma & Diagnostic Private Limited was incorporated on 29 Jun 2022.
The authorized share capital of Ghl Pharma & Diagnostic Private Limited is ₹ 15.00 Cr and paid-up capital is ₹ 10.01 Cr.
Currently 6 directors are associated with Ghl Pharma & Diagnostic Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ghl Pharma & Diagnostic Private Limited is E-18 Defence Colony India, Delhi, 110024.
The corporate identification number (CIN) of Ghl Pharma & Diagnostic Private Limited is U85110DL2022PTC400942 and the company number is 400942 as per Ministry of Corporate Affairs (MCA).
As Per 2023 financial reports, 170 employees are currently employed by Ghl Pharma & Diagnostic Private Limited.
The most recent Balance Sheet for Ghl Pharma & Diagnostic Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
SK